Astellas Pharma has received conditional approval in Japan for Izervay to suppress geographic atrophy (GA) growth.

The aim of the blue badge scheme is to help people with severe mobility problems caused by visible and non-visible disabilities to access goods and services, by allowing them to park close to their ...